Article (Scientific journals)
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Waked, Anthony; Crabbé, Mélissa; Neirinckx, Virginie et al.
2024In EJNMMI Radiopharmacy and Chemistry
Peer Reviewed verified by ORBi
 

Files


Full Text
Waked et al..pdf
Author preprint (70.29 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Waked, Anthony  ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, et biochimie humaine
Crabbé, Mélissa;  SCK CEN - Belgian Nuclear Research Centre [BE]
Neirinckx, Virginie ;  Université de Liège - ULiège > Département des sciences biomédicales et précliniques ; Université de Liège - ULiège > GIGA > GIGA Neurosciences
Rodriguez Pérez, Sunay;  SCK CEN - Belgian Nuclear Research Centre [BE]
Wellens, Jasmien;  SCK CEN - Belgian Nuclear Research Centre [BE]
Rogister, Bernard  ;  Université de Liège - ULiège > GIGA > GIGA Neurosciences - Nervous system disorders and therapy
Benotmane, Abderrafi;  SCK CEN - Belgian Nuclear Research Centre [BE]
Vermeulen, Koen;  SCK CEN - Belgian Nuclear Research Centre [BE]
Language :
English
Title :
Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma
Publication date :
2024
Journal title :
EJNMMI Radiopharmacy and Chemistry
eISSN :
2365-421X
Publisher :
Springer, Cham, Switzerland
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 03 July 2024

Statistics


Number of views
209 (4 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
0
Scopus citations®
without self-citations
0
OpenAlex citations
 
0

Bibliography


Similar publications



Contact ORBi